SUMMARY A patient receiving D-penicillamine for rheumatoid arthritis developed a lymphoma, therapy for which resulted not only in haematological resolution but marked remission of rheumatoid disease activity, including radiological improvement.
A 51-year-old furnace engineer presented with a three-year history of polyarthritis, which had made him give up work eight months previously. Examination revealed large rheumatoid nodules over both elbows, swollen extensor sheaths over the wrists, swollen metacarpophalangeal joints, and flexor deficits of the finger joints.
Investigations revealed a positive rheumatoid factor, latex titre 1:160, low titre antinuclear factor 1:64 (IgG class), plasma viscosity 1-86 cp (normal 1-50-1-72 cp),total white cell count 4 6x109/l. X-rays showed erosions of the heads of the second left and second and third right metacarpophalangeal joints (Figs. la and 2a).
He was taking 7.2 g daily of salicylates (having found more recently developed non-steroidal antiinflammatory agents no better), and was therefore started on D-penicillamine 250 mg daily. The dose was doubled after six weeks, increased to 625 mg daily three months later, then 750 mg daily six months after commencement. At this stage proteinuria occurred, 1.5 g being excreted in 24 h. No drug adjustment was made and it disappeared within two months. Simultaneously leucopenia (3-1 x 109/l) was noted, and the differential white cell count was normal, no immature forms being present.
Accepted for publication 10 The count rose to normal within two months without any alteration in dose. He improved considerably, the mean plasma viscosity falling from 1*93 to 1-7 cp. Subjectively there was reduction in early morning stiffness from 2 h to 1 h, and his nodules became smaller.
Twenty-six months after beginning D-penicillamine, he developed an enlarging painless swelling round the left clavicle.
Examination showed a non-tender 5 cm diameter hard round mass arising over the medial third of the clavicle. There was no lymphadenopathy, hepatosplenomegaly, or bruising. The mass was excised under general anaesthesia. Histology showed a lymphoblastic lymphoma (undesignated).1 A trephine bone marrow examination showed focal areas of lymphocytes, considered to be consistent with lymphomatous infiltration. Other investigations included normal chest and pelvic x-rays, the lumbar spine showed spondylosis only, and CT scan of the abdomen was normal. Peripheral blood lymphocytes did not show a B cell clone, but T cell numbers were slightly reduced, 48% forming sheep cell rosettes (control 62%). Serum protein electrophoresis showed no evidence of paraprotein or immunosuppression. The D-penicillamine was stopped.
He received combination therapy with cyclophosphamide, vincristine, adriamycin, and prednisolone. Six courses of treatment were given at monthly intervals.
Repeat marrow examination at six months showed no evidence of lymphomatous involvement. Six months after discontinuation of chemotherapy he was in complete remission both from the lymphoma and the rheumatoid arthritis. There was no morning stiffness, no soft tissue swelling or flexor deficit, and the elbow nodules had disappeared. Rheumatoid factor (latex) was only 1:20. He was receiving no medication. X-rays of his hands showed evidence of recortication of the metacarpal head erosions (Figs lb and 2b) . Remission of the arthritis lasted for 16 months, at which time the plasma viscosity was 1-78 cp, and the rheumatoid factor titre 1:20. Symptoms then gradually reappeared, the rheumatoid factor titre rose to 1:160 and has remained so for six months. 
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